This report shows patients by high and moderate risk as defined by ATAGI and utilised in the national roadmap.
It uses the same categories as the 'General' COVID-19 report:
- Dose 1 Categories
- Dose 1 Astrazeneca
- Dose 1 Pfizer (Comirnaty)
- Dose 1 Moderna (Spikevax)
- Dose 1 Other
- Dose 2 Categories
- Dose 2 Astrazeneca
- Dose 2 Pfizer (Comirnaty)
- Dose 2 Moderna (Spikevax)
- Dose 2 Other
- Declined
- Not Recorded
We are using the following criteria to determine high and medium risk (from https://www.healthdirect.gov.au/coronavirus-covid-19-groups-at-higher-risk-faqs):
People are at high risk of serious illness from COVID-19 if they:
- are age 70 years and older
- have had an organ transplant and are on immune suppressive therapy
- have had a bone marrow transplant in the past 24 months
- are on immune suppressive therapy for graft versus host disease
- have had a blood cancer — for example, leukaemia, lymphoma or myelodysplastic syndrome — in the past 5 years
- are having chemotherapy or radiotherapy
People are at moderate risk of serious illness from COVID-19 if they have:
- chronic kidney failure
- heart disease
- chronic lung disease — but excluding mild or moderate asthma
- a non-blood cancer in the past 12 months
- diabetes
- severe obesity with a BMI (body mass index) of 40 or more
- chronic liver disease
- some neurological conditions such as stroke or dementia
- some chronic inflammatory conditions and treatments
- other primary or acquired immunodeficiencies